Adipotide vs AOD-9604 — mechanism, half-life, dosing, and research status compared. Which is right for your protocol?
Adipotide (FTPP) is an experimental peptidomimetic that selectively targets and destroys blood vessels supplying white adipose tissue. It consists of a homing peptide that binds prohibitin on adipose vasculature, linked to a proapoptotic sequence that triggers cell death in the t...
Calculate Adipotide dose →AOD-9604 (Anti-Obesity Drug 9604) is a synthetic fragment of human growth hormone (hGH), specifically the C-terminal region spanning amino acids 176-191 with an additional tyrosine at position 177. It was designed to isolate the fat-metabolizing properties of hGH without the IGF-...
Calculate AOD-9604 dose →| Parameter | Adipotide | AOD-9604 |
|---|---|---|
| Category | Metabolic & Mitochondrial | Metabolic & Mitochondrial |
| Research | Preclinical | Phase IIb (Discontinued) |
| Half-Life | - | ~30 minutes |
| Typical Dose | 1 mg/kg body weight | 300 µg |
| Frequency | Daily (research cycles) | Once daily (fasted) |
| Route | Subcutaneous | Subcutaneous / Oral |
| FDA Status | Not Approved | Not Approved |
Use ASCEND's free reconstitution calculator to get exact syringe draw amounts for your vial.
For research use only. Not medical advice. ASCEND does not conduct or endorse any specific research protocol. Always consult relevant scientific literature and regulatory guidelines.